
SOPHiA DDM™
by SOPHiA GENETICS
SubscriptionCategories
Data AnalysisPredictive AnalyticsPrecision Medicine
Description
AI-driven and cloud-powered platform for generating real-time, actionable insights for patients with cancer and rare disorders.
Summary
SOPHiA DDM™ is at the forefront of democratizing data-driven medicine by providing clinicians with AI-driven insights across oncology and inherited disorders. The platform streamlines workflows, expedites results, and fosters precision medicine expertise, ensuring data privacy and security. It supports healthcare professionals and BioPharma companies throughout the drug development continuum, optimizing clinical trial development and market access strategies.
Use Cases
- Oncologists use SOPHiA DDM™ to accurately assess homologous recombination deficiency, optimizing decision-making for cancer patients.
- BioPharma companies leverage SOPHiA DDM™ for AI-driven insights to optimize clinical trial development and market access strategies.
Platforms
Web
Regulatory Status
CE-IVD products for In Vitro Diagnostic Use in the EEA, the UK, Switzerland, and Israel.API Available
NoAdded to Directory
6/21/2025Target Customer
Enterprise